Mapping Neurodegeneration with Spatial Glycoproteomics  - Top-Institutions - MDSpire

Mapping Neurodegeneration with Spatial Glycoproteomics 

Combined proteomic and glycomic profiling reveals molecular signatures of Alzheimer’s and Lewy body disease 

  • March 16, 2026

  • 3 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Boston University Chobanian & Avedisian School of Medicine
    Boston University Chobanian & Avedisian School of Medicine

    Boston, MA

    Key Differentiators

    • Neurodegeneration
    • Mass Spectrometry
    • Proteomics
    • Glycomics

  • #2

    Massachusetts Institute of Technology (MIT) - Koch Institute for Integrative Cancer Research
    Massachusetts Institute of Technology (MIT) - Koch Institute for Integrative Cancer Research

    Cambridge, MA

    Key Differentiators

    • Mass Spectrometry
    • Neurobiology
    • Proteomics

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurodegeneration
    • Proteomics
    • Neuropathology

  • #4

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Neuroscience
    • Mass Spectrometry
    • Proteomics

  • #5

    University of California, San Diego (UCSD) School of Medicine
    University of California, San Diego (UCSD) School of Medicine

    San Diego, CA

    Key Differentiators

    • Neurodegeneration
    • Proteomics
    • Glycomics

Original Source(s)

Mapping Neurodegeneration with Spatial Glycoproteomics 

  • March 16, 2026

Related Content

Tau Oligomers Promote Invagination of the Nuclear Lamina and Alter Chromatin Structure in Alzheimer's Disease

Wearable EEG devices in the detection of mild cognitive impairment: a systematic review

The duality of disease: the Alzheimer’s disease dilemma through the lens of nosos and asthenia